All In Biotech

Free tool

FAERS Monitor: Yaz

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 021873 or its brand name (Yaz, Drospirenone, Ethinyl Estradiol). Reports on generic versions are filed under their own applications.

Reports

31,300

Serious

24,198

77% of reports

Hospitalization

14,360

Death reported

376

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • pain10,333
  • injury8,764
  • pulmonary embolism6,448
  • deep vein thrombosis5,876
  • anxiety5,267
  • emotional distress5,096
  • cholecystitis chronic4,476
  • gallbladder disorder3,273
  • cholelithiasis3,258
  • general physical health deterioration2,535
  • abdominal pain2,119
  • nausea2,023
  • anhedonia1,786
  • dyspnoea1,582
  • thrombosis1,564

Reports by year received

View as table
YearReports
20041
200619
2007213
20082,509
20092,361
20101,750
20118,672
20127,360
20133,487
20141,798
2015588
2016450
2017278
2018271
2019247
2020239
2021189
2022202
2023203
2024145
2025175
2026143

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,022,859 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
cholecystitis chronicSignal4,4761349.31284.12,004,429
gallbladder disorderSignal3,273150.6145.2397,501
injurySignal8,76495.593.7720,120
cholelithiasisSignal3,25874.071.5211,647
deep vein thrombosisSignal5,87666.765.1346,927
anhedoniaSignal1,78648.946.778,198
pulmonary embolismSignal6,44848.847.7282,886
emotional distressSignal5,09629.528.7135,081
general physical health deteriorationSignal2,53515.014.532,639
thrombosisSignal1,56413.312.717,501
anxietySignal5,26712.712.356,224
painSignal10,33311.511.3100,107
abdominal painSignal2,1196.25.99,188
dyspnoea1,5821.91.8667
nausea2,0231.71.6630

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.